Literature DB >> 19685279

Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe.

N Sangala1, R W Lee, C Horsfield, D J A Goldsmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19685279     DOI： 10.1007/s11255-009-9627-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  13 in total

1.  Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects.

Authors:  J D MORROW; H A SCHROEDER; H M PERRY
Journal:  Circulation       Date:  1953-12       Impact factor: 29.690

2.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

3.  Fulminating hydralazine-induced lupus pneumonitis.

Authors:  Belinda Birnbaum; Gurdip S Sidhu; Robert L Smith; Michael H Pillinger; Clement E Tagoe
Journal:  Arthritis Rheum       Date:  2006-06-15

4.  Systemic vasculitis resembling periarteritis nodosa in the lupus-like syndrome induced by hydralazine.

Authors:  A Martinez-Vea; I Ferrer; C Carcía; E Mayayo; J A Oliver; C Richart
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

5.  Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus.

Authors:  P E Spronk; H Bootsma; G Horst; M G Huitema; P C Limburg; J W Tervaert; C G Kallenberg
Journal:  Br J Rheumatol       Date:  1996-07

6.  Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.

Authors:  L Nässberger; A G Sjöholm; H Jonsson; G Sturfelt; A Akesson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment.

Authors:  H A Cameron; L E Ramsay
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

8.  Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.

Authors:  A K Short; C M Lockwood
Journal:  QJM       Date:  1995-11

9.  Immune complex glomerulonephritis in hydralazine-induced SLE.

Authors:  K S Shapiro; V W Pinn; J T Harrington; A S Levey
Journal:  Am J Kidney Dis       Date:  1984-01       Impact factor: 8.860

Review 10.  Pathology and immunology of lupus glomerulonephritis: can we bridge the two?

Authors:  Helen Liapis; George C Tsokos
Journal:  Int Urol Nephrol       Date:  2007-01-12       Impact factor: 2.266
View more
  4 in total

1.  Antineutrophil cytoplasmic antibodies, autoimmune neutropenia, and vasculitis.

Authors:  Peter C Grayson; J Mark Sloan; John L Niles; Paul A Monach; Peter A Merkel
Journal:  Semin Arthritis Rheum       Date:  2011-04-19       Impact factor: 5.532

2.  Hydralazine-induced lupus erythematosis.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-09       Impact factor: 3.738

3.  Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.

Authors:  Pierre-Andre Jarrot; Laurent Chiche; Baptiste Hervier; Laurent Daniel; Vincent Vuiblet; Nathalie Bardin; Daniel Bertin; Benjamin Terrier; Zahir Amoura; Emmanuel Andrés; Eric Rondeau; Mohamed Hamidou; Jean-Loup Pennaforte; Philippe Halfon; Eric Daugas; Bertrand Dussol; Xavier Puéchal; Gilles Kaplanski; Noemie Jourde-Chiche
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 4.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.